Northstar Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-2,118
| Closed | -$280K | – | 155 |
|
2024
Q4 | $280K | Sell |
2,118
-100
| -5% | -$13.2K | 0.05% | 124 |
|
2024
Q3 | $323K | Sell |
2,218
-100
| -4% | -$14.6K | 0.06% | 120 |
|
2024
Q2 | $318K | Sell |
2,318
-653
| -22% | -$89.6K | 0.06% | 116 |
|
2024
Q1 | $408K | Hold |
2,971
| – | – | 0.08% | 100 |
|
2023
Q4 | $404K | Sell |
2,971
-98
| -3% | -$13.3K | 0.09% | 96 |
|
2023
Q3 | $375K | Sell |
3,069
-344
| -10% | -$42.1K | 0.09% | 100 |
|
2023
Q2 | $433K | Buy |
3,413
+44
| +1% | +$5.59K | 0.1% | 93 |
|
2023
Q1 | $435K | Sell |
3,369
-200
| -6% | -$25.8K | 0.11% | 91 |
|
2022
Q4 | $469K | Sell |
3,569
-401
| -10% | -$52.7K | 0.13% | 87 |
|
2022
Q3 | $465K | Buy |
3,970
+15
| +0.4% | +$1.76K | 0.14% | 86 |
|
2022
Q2 | $465K | Sell |
3,955
-150
| -4% | -$17.6K | 0.13% | 90 |
|
2022
Q1 | $535K | Sell |
4,105
-200
| -5% | -$26.1K | 0.13% | 93 |
|
2021
Q4 | $657K | Buy |
4,305
+100
| +2% | +$15.3K | 0.16% | 84 |
|
2021
Q3 | $680K | Hold |
4,205
| – | – | 0.18% | 83 |
|
2021
Q2 | $688K | Sell |
4,205
-200
| -5% | -$32.7K | 0.18% | 83 |
|
2021
Q1 | $663K | Buy |
4,405
+1
| +0% | +$151 | 0.19% | 81 |
|
2020
Q4 | $667K | Sell |
4,404
-100
| -2% | -$15.1K | 0.2% | 78 |
|
2020
Q3 | $610K | Sell |
4,504
-99
| -2% | -$13.4K | 0.21% | 79 |
|
2020
Q2 | $629K | Sell |
4,603
-601
| -12% | -$82.1K | 0.25% | 70 |
|
2020
Q1 | $561K | Sell |
5,204
-339
| -6% | -$36.5K | 0.26% | 70 |
|
2019
Q4 | $668K | Sell |
5,543
-400
| -7% | -$48.2K | 0.26% | 73 |
|
2019
Q3 | $591K | Sell |
5,943
-20
| -0.3% | -$1.99K | 0.25% | 73 |
|
2019
Q2 | $651K | Sell |
5,963
-1,279
| -18% | -$140K | 0.28% | 73 |
|
2019
Q1 | $810K | Buy |
7,242
+180
| +3% | +$20.1K | 0.36% | 67 |
|
2018
Q4 | $662K | Sell |
7,062
-1,321
| -16% | -$124K | 0.34% | 66 |
|
2018
Q3 | $1.02M | Sell |
8,383
-297
| -3% | -$36.2K | 0.47% | 53 |
|
2018
Q2 | $920K | Buy |
8,680
+450
| +5% | +$47.7K | 0.47% | 56 |
|
2018
Q1 | $878K | Buy |
+8,230
| New | +$878K | 0.46% | 55 |
|